These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 487818)

  • 1. First year clinical experience with six levonorgestrel rods as subdermal contraception.
    Faundes A; Brache de Mejias V; Leon P; Robertson D; Alvarez F
    Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
    Roy S; Stanczyk F; Mishell DR; Lumkin M; Gentzschein E
    Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
    Roy S; Mishell DR; Robertson DN; Krauss RM; Lacarra M; Duda MJ
    Am J Obstet Gynecol; 1984 Apr; 148(7):1006-13. PubMed ID: 6424474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
    Moore DE; Roy S; Stanczyk FZ; Mishell DR
    Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
    Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
    Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new delivery system for contraceptive steroids.
    Segal S
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
    Diaz S; Pavez M; Miranda P; Robertson DN; Sivin I; Croxatto HB
    Contraception; 1982 May; 25(5):447-56. PubMed ID: 6809423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
    Robertson DN; Sivin I; Nash HA; Braun J; Dinh J
    Contraception; 1983 May; 27(5):483-95. PubMed ID: 6411428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel.
    Holma P; Robertson DN
    Contraception; 1985 Aug; 32(2):163-71. PubMed ID: 3935372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual impact of contraception.
    Stubblefield PG
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE; Odlind V; Johansson ED; Nordström ML
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
    Croxatto HB; Díaz S; Brandeis A; Pavez M; Johansson ED
    Contraception; 1985 Jun; 31(6):643-54. PubMed ID: 3930143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year experience with NORPLANT subdermal contraception.
    Sivin I; Sanchez FA; Diaz S; Holma P; Coutinho E; McDonald O; Robertson DN; Stern J
    Fertil Steril; 1983 Jun; 39(6):799-808. PubMed ID: 6406273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdermal progestin implant contraception.
    Darney PD
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.